Literature DB >> 23440588

Nonpolypoid colorectal neoplasms: a challenge in endoscopic surveillance of patients with Lynch syndrome.

E J A Rondagh1, S Gulikers, E B Gómez-García, Y Vanlingen, Y Detisch, B Winkens, H F A Vasen, A A M Masclee, S Sanduleanu.   

Abstract

BACKGROUND AND STUDY AIMS: Patients with Lynch syndrome may develop colorectal cancer (CRC), despite intensive colonoscopic surveillance. Nonpolypoid colorectal neoplasms might be a major contributor to the occurrence of these cancers. The aim of this case - control study was to compare the endoscopic appearance of colorectal neoplasms between patients with Lynch syndrome and control individuals at average risk for CRC. PATIENTS AND METHODS: The endoscopists at the Maastricht University Medical Center were first given training to ensure familiarity with the appearance and classification of nonpolypoid lesions. Patients with Lynch syndrome and patients at average risk for CRC who underwent elective colonoscopy at the Center were prospectively included. Nonpolypoid lesions were defined as lesions with a height of less than half the diameter, and advanced histology was defined as the presence of high grade dysplasia or early cancer.
RESULTS: A total of 59 patients with Lynch syndrome (mean age 48.7 years, 47.5 % men) and 590 matched controls (mean age 50.2 years, 47.5 % men) were included. In patients with Lynch syndrome, adenomas were significantly more likely to be nonpolypoid than they were in controls: 43.3 % vs. 16.9 % (OR 3.60, 95 %CI 1.90 - 6.83; P < 0.001). This was particularly true for proximal adenomas: 58.1 % vs. 16.3 % (OR 6.93, 95 %CI 2.92 - 16.40; P < 0.001). Adenomas containing advanced histology were more often nonpolypoid in patients with Lynch syndrome than in controls (4/5, 80.0 % vs. 5/17, 29.4 %; P = 0.19). Serrated polyps were also more often nonpolypoid in patients with Lynch syndrome than in controls: 49.2 % vs. 20.4 % (OR 3.57, 95 %CI 1.91 - 6.68; P < 0.001).
CONCLUSIONS: In patients with Lynch syndrome, colorectal neoplasms are more likely to have a nonpolypoid shape than those from average risk patients, especially in the proximal colon. These findings suggest that proficiency in recognition and endoscopic resection of nonpolypoid colorectal lesions are needed to ensure colonoscopic prevention against CRC in this high risk population. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23440588     DOI: 10.1055/s-0032-1326195

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  13 in total

1.  Sessile serrated adenomas: why conventional endoscopy is okay for unconventional polyps.

Authors:  Stephen J Lanspa; Henry T Lynch
Journal:  Dig Dis Sci       Date:  2014-12       Impact factor: 3.199

2.  Improving the quality of endoscopic surveillance of patients with lynch syndrome.

Authors:  Silvia Sanduleanu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

3.  Colonoscopy and chromoscopy in hereditary colorectal cancer syndromes.

Authors:  Erin Jenkins Wessling; Stephen J Lanspa
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

Review 4.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 5.  Potential risks associated with the use of ionizing radiation for imaging and treatment of colorectal cancer in Lynch syndrome patients.

Authors:  Mingzhu Sun; Jayne Moquet; Michele Ellender; Simon Bouffler; Christophe Badie; Rachel Baldwin-Cleland; Kevin Monahan; Andrew Latchford; David Lloyd; Susan Clark; Nicola A Anyamene; Elizabeth Ainsbury; David Burling
Journal:  Fam Cancer       Date:  2022-06-20       Impact factor: 2.375

6.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

7.  Quality of colonoscopy in Lynch syndrome.

Authors:  Yaron Niv; Gabriela Moeslein; Hans F A Vasen; Judith Karner-Hanusch; Jan Lubinsky; Christoph Gasche
Journal:  Endosc Int Open       Date:  2014-10-24

8.  Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).

Authors:  N C Ramchander; N A J Ryan; E J Crosbie; D G Evans
Journal:  BMC Med Genet       Date:  2017-04-05       Impact factor: 2.103

9.  Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report.

Authors:  Masashi Utsumi; Kohji Tanakaya; Yutaka Mushiake; Tomoyoshi Kunitomo; Isao Yasuhara; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Hideki Aoki; Hitoshi Takeuchi
Journal:  World J Surg Oncol       Date:  2017-08-01       Impact factor: 2.754

10.  Features of incident colorectal cancer in Lynch syndrome.

Authors:  Tanja E Argillander; Jan J Koornstra; Mariette van Kouwen; Alexandra Mj Langers; Fokko M Nagengast; Juda Vecht; Wouter H de Vos Tot Nederveen Cappel; Evelien Dekker; Peter van Duijvendijk; Hans Fa Vasen
Journal:  United European Gastroenterol J       Date:  2018-06-11       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.